ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
Ann Oncol. 2022
S. Filetti, C. Durante, D. M. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti & A. Berruti, on behalf of the ESMO Guidelines Committee
This update refers to the Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. S. Filetti, C. Durante, D. Hartl et al. Ann Oncol 2019; 30(12): 1856-1883.
- This special article provides updated treatment recommendations on thyroid cancer.
- New targeted systemic therapies have now been approved for treating patients with advanced/metastatic thyroid cancers.
- This article summarises these new options and the order in which they should be used.
- Recommendations are based on available scientific data and the authors' collective expert opinion.
- Authorship includes a multidisciplinary group of thyroid cancer experts.